India to Yemen: Empagliflozin Export Trade Route

The India to Yemen Empagliflozin corridor is one of India's established pharmaceutical export routes, with 14 shipments documented worth a combined $221.0K USD. The route is dominated by SCOTT EDIL PHARMACIA LIMITED, which alone accounts for roughly 55% of all export value, reflecting the consolidated nature of India's empagliflozin manufacturing sector.

Across 6 active suppliers, the average shipment value stands at $15.8K USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Sea freight dominates at 73% of all shipments, consistent with empagliflozin's non-urgent bulk-order profile.

Shipment activity peaks during January–March, with an average transit time of 30 days port-to-port. The route has recorded an annual growth rate of 19.8%, placing it at rank #19 among India's top empagliflozin export destinations globally.

On the import side, key buyers of Indian empagliflozin in Yemen include ALKURIMI ISLAMIC BANK, ALKURAIMI ISLAMIC BANK, TO THE ORDER OF and 5 others. ALKURIMI ISLAMIC BANK is the single largest importer with 1 shipments valued at $56.3K USD.

India's empagliflozin exports to Yemen are driven primarily by a handful of large-scale manufacturers. SCOTT EDIL PHARMACIA LIMITED with 7 shipments leads the pack, a pattern common in generic pharmaceutical corridors where manufacturing scale creates significant cost advantages. The presence of 6 active exporters signals a competitive but concentrated market — buyers in Yemen benefit from supplier diversity while the top tier handles the majority of volume.

The top 3 suppliers — SCOTT EDIL PHARMACIA LIMITED, METROCHEM API PRIVATE LIMITED, K C LABORATORIES — together account for 90% of total trade value on this route. The average shipment value of $15.8K USD reflects a mix of bulk commercial orders and smaller specialty shipments.

Beyond the primary product category, shipments on this route include closely related formulations such as harmless pharmaceutical medicines finished formulation empagliflozin 25 mg tabletsbatch no:2416591t001 and harmless pharmaceutical medicines finished formulation empagliflozin 10mg tablets batch no.2316590t002nos, suggesting that buyers in Yemen tend to consolidate orders across related product lines from the same Indian supplier.

On the buying side, ALKURIMI ISLAMIC BANK is the largest importer with 1 shipments worth $56.3K USD — representing 25% of all empagliflozin imports from India on this route. A total of 8 buyers are active on this corridor.